This week in gene and cell therapy - 7 September 2018

Gene and cell therapy headlines 3 - 7 September

4D Molecular Therapeutics partners with AstraZeneca and Roche to develop gene therapy products

Clinical trial with iPS cell therapy for heart disease announced

Vertex announces clinical trial of gene editing for beta thalassemia

Immune response against gene therapy overcome with plasmid in mice

Encouraging results for trial of Sangamo's trial of in vivo gene editing for Hunter syndrome

T cell therapy achieves regression in metastatic liver cancer (7 month follow up)